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Relieving chronic breathlessness  
is a human right
Abstract
Chronic breathlessness, defined as breathlessness that persists despite optimising the treatment of un-
derlying causes, is recognised by recent international consensus as a distinct clinical syndrome. Across 
our communities, population-based studies of chronic breathlessness expose an enormous burden from 
this. Among the palliative care population, one in four people die with severe breathlessness despite treat-
ment from a palliative care service. Recently, the relief of breathlessness was claimed to be a human right, 
particularly when there are treatments available to alleviate the unnecessary suffering caused by chronic 
breathlessness. The timely recognition of, and response to chronic breathlessness is a crucial clinical skill.
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Introduction
For many people, breathlessness is an ever present, 
lived, daily experience. One patient described it as: “…
an effort just to be”.
Chronic breathlessness — breathlessness that per-
sists despite optimising the treatment of underlying 
causes — is a distinct clinical syndrome defined by 
recent international consensus process [1]. As we rec-
ognise chronic breathlessness across our community, 
we need to consider how this syndrome affects peo-
ple’s lives on a day-to-day basis. These are people for 
whom breathlessness impacts on the ability to bathe, 
toilet, dress and prepare food, for months or years of 
life [1]. Such chronicity has a toll on the physical and 
mental health components of quality of life, when 
adjusted for age and sex across the community [2]. As 
clinicians, we often assume that when we see people 
acutely short of breath, their breathlessness settles 
between episodes of care. In fact, for many of these 
people, we see acute-on-chronic breathlessness with 
significant ongoing breathlessness experienced [3].
Extensive data have demonstrated over a long 
period of time that with increasing severity of chronic 
obstructive pulmonary disease (COPD), functional 
status declines markedly. This sees people with GOLD 
grade IV exerting themselves at approximately one 
third the distance that healthy, age-matched volun-
teers do [4]. Even people with GOLD grade I COPD, 
their daily exertion is still approximately 80% of age-
matched people with no respiratory disease [4]. This 
decrement represents the mobility forgone in order 
to avoid breathlessness. 
There are very few population-based studies of 
breathlessness. A study by Frostad et al. published 
in 2006 followed almost 20,000 people in Oslo for 
thirty years [5]. The higher the symptom score for 
breathlessness, the more likely that death was going 
to ensue from COPD. This reached a hazard ratio of 
9.6 (95% CI 5.1, 18.3) for death from COPD, when 
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terestingly, does not mention palliation [15]. Arguably, 
this is a significant oversight given the importance of 
the 1978 declaration. Moving to contemporary times, 
the 67th World Health Assembly noted that “... access 
to palliative care ... contributes to the realisation of 
the right to the enjoyment of the highest attainable 
standard of health and well-being ... as an ethical 
responsibility of health systems” [16]. It further notes, 
that health care professionals have a duty to alleviate 
pain and [other] suffering.
To that end, it can be argued that the relief of 
breathlessness (whose prevalence is akin to levels 
of pain and fatigue for many people with chronic 
complex illnesses and certainly with chronic progres-
sive illnesses) is a right particularly when there are 
evidence-based treatments available to alleviate the 
unnecessary suffering caused by this syndrome. One 
can argue that 30 years ago many clinicians shrugged 
their shoulders when patients with cancer had pain, 
claiming that it was expected that they would have 
pain because they have cancer. We would no longer 
accept that argument anywhere in the world. Why 
should we accept the same argument when someone 
with COPD is so limited in what they can do?
There is now an excellent evidence base in the lit-
erature relating to breathlessness. The Canadian Tho-
racic Society breathlessness ladder gives clear guid-
ance to:
• addressing all reversible causes of breathlessness;
• utilising non–pharmacological interventions; and 
• ensuring that the pharmacological options use 
the best available evidence base which currently is 
regular, low-dose, extended-release morphine [17].
There is an evidence base available for the safe 
use of regular low-dose extended-release morphine to 
reduce chronic breathlessness that is as strong as any 
other evidence base that we have in the therapeutic 
interventions in palliative care [18, 19].
There are academic, policy and clinical responsibili-
ties that need to be put in place if we are to accept that 
the relief of chronic breathlessness is a human right.
• Academically, we need to develop more predicta-
ble and acceptable therapies with clear delineation 
of patient groups who would benefit, and those 
who may more predictably experience harms. 
• The policy responsibilities are to ensure access 
to medications particularly given that morphine 
is otherwise significantly restricted across our 
communities.
• Clinically, there is a responsibility to actively seek 
out and identify people experiencing this clinical 
syndrome and use the best available evidence to 
reduce its impact on patients and their caregivers. 
Of note, we often ask: „Are you breathless?”, when 
associated with higher breathlessness scores. Another 
Norwegian study that followed people for 12 years 
across the age range indicated, that persistent respira-
tory symptoms were evident in 6.9% of women and 
4.3% of men [6]. Australian population-based data 
indicates that from the modified Medical Research 
Council (mMRC) scale, 8.9% of people have a score 
of ≥ 2, 1% had a score of ≥ 3 and one in three hundred 
had a score of 4 [7]. This reflects an enormous burden 
of chronic breathlessness across the community. Of 
note, that latter group is almost invisible to health 
services, because they are house bound and present 
only with the most severe exacerbations.
When we consider the palliative care popula-
tion, we see that one in four people die with severe 
breathlessness despite treatment from a palliative care 
service [8]. Those most likely to have breathlessness 
at the end of life are those with respiratory diseases 
such as COPD [9]. Again, a scale analogous to the 
mMRC breathlessness scores in people with COPD is 
a far better prognostic factor than looking at forced 
expiratory volume in one second (FEV1) [10]. Data 
from 50 years ago at a population level indicated 
that breathlessness was a predictor of short-term 
mortality with a mortality ratio of 2.08 at 24 months 
in a population survey of more than 1million people 
across the United States of America [11].
Claiming a “right”
It is an extremely serious issue to claim something 
as a right. For example, it is estimated that last year 
1.5 million people in the world died because they did 
not have access to clean water. As such, a fundamental 
to human existence, clean water should arguably be 
seen as a “right”. Health has been proposed as a “right”, 
again fundamental to our being [12]. If we are to 
live with dignity, then we must be able to attain the 
best level of health [12]. As outlined in the 1946 con-
stitution of the World Health Organisation, health 
is “a state of complete physical, mental and social 
well-being and not merely the absence of disease or 
infirmity” [13]. It goes on to say, that there should be 
“the enjoyment of the highest attainable standard of 
“physical and mental” health as a fundamental right of 
every human being”. Of note, this is not a right to be 
healthy, but to attain the highest standard of health 
possible [12]. In the 1966 International Covenant on 
Economic, Social and Cultural Rights it asserts the 
right for everyone to enjoy the highest attainable 
level of health together with access to essential med-
ication and health-related education [14]. Later, the 
Declaration of Alma-Ata talks of promotion of health, 
prevention of health, cure and rehabilitation, but, in-
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we should be asking: “What have you given up in 
order to avoid being breathless?”.
Ultimately, as with other symptoms, there is a need 
to develop our evidence base and apply it to maximise 
benefits and minimise harms. Our responsibilities as 
clinicians and policy makers are to relieve suffering 
with the tools that are available. The evidence base 
available here demands that we respond in order to 
reduce the burden from chronic breathlessness across 
our community.
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